Construction BUSINESS

Grifols invests €77m in Dublin plant

 Breaking News
  • 3D printed homes success spurs interest in 3D construction careers In response to increased demand, LMETB’s Advanced Manufacturing Training Centre of Excellence (AMTCE) in Dundalk has announced monthly courses in Advanced Construction Technologies, which includes 3D concrete printing, to run throughout 2025,...
  • McGill and Partners bolsters its Irish business McGill and Partners, the global specialty insurance and reinsurance broker, has appointed John Barry and Jack Farrell as partners in specialty broking in Ireland. John joins McGill and Partners from...
  • Belfast Harbour launches ‘transformative’ strategy Belfast Harbour has unveiled a new strategy setting out an ambitious programme to invest more than £300m in capital projects across the port and Harbour Estate over the next five...
  • Bouygues and Ecocem cement partnership Bouygues Construction and Ecocem have signed a global innovation partnership. Following thorough laboratory and rigorous full-scale testing by Bouygues Construction’s R&D and Innovation team in collaboration with Ecocem, the goal...
  • BusConnects Client Partner selected Jacobs-led team to manage major infrastructure project for Ireland’s National Transport Authority. Jacobs has been selected by the National Transport Authority (NTA) in Ireland to provide Client Partner delivery services...

Grifols invests €77m in Dublin plant

March 11
11:43 2016

Grifols_plant_Grange CastleSpanish plasma pharmaceuticals group Grifols has announced plans to invest another €77m in its biologics plant at Grange Castle in Co Dublin.

The company said it was bringing forward plans for the construction of a purification plant for the protein “albumin” to meet rising demand.

Construction will begin towards the end of this year, with the plant expected to be ready by early 2020.

Last October Grifols announced 140 jobs and a €90m investment in its Bioscience Division global operations centre in Grange Castle in Dublin, Ireland.

Grifols is one of the global leading companies in the manufacture of plasma-based medicines.

IDA Ireland said the latest Grifols investment will add to the growing biologics manufacturing cluster in Ireland, which is the fastest growing subsector in pharmaceutical industry.

“Grifols only opened its plant at Grange Castle last year and already we can see how it is contributing to the company’s global operations. Ireland is rapidly developing an internationally recognised hub for biologics and Grifols’ latest investment will strengthen this further,” said IDA’s chief executive Martin Shanahan.

He noted that the biologics sector had grown to over 6,000 people in Ireland in the last 10 years and accounted for over €10bn of investment.

It has also created significant secondary employment in construction and other services.

About Author

admin

admin

Related Articles

Constrcution Summit

The Magazine – Construction Business

The Magazine – Construction Summit – 2023

The Magazine – Construction Summit – 2024

New Subscriber

    Subscribe Here


    Advertisements